Investigator Site - San Francisco

San Francisco, California 94143

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Malignant Solid Tumor, Metastasis

Studies at this site

• A Study of Etirinotecan Pegol (NKTR-102) Versus Treatment of Physician's Choice (TPC) in Patients With Metastatic Breast Cancer Who Have Stable Brain Metastases and Have Been Previously Treated With an Anthracycline, a Taxane, and Capecitabine — Completed
• An Extension Study of NKTR-102 in Cancer Patients Previously Enrolled in NKTR-102 Studies — Completed